Business Standard

Monday, December 23, 2024 | 12:43 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Reddy's launches cholesterol-lowering Colesevelam HCl tablets in US

Alkem Labs, Glenmark Pharmaceuticals and Impax Labs were also granted product approval to manufacture and market Colesevelam HCl tablets by the US drug regulator

reddy, dr reddy's
Premium

Dr Reddy's laboratory

BS Reporter Hyderabad
Dr Reddy's Laboratories Limited announced on Tuesday that it has launched cholesterol lowering Colesevelam HCl Tablets, a therapeutic equivalent generic version of Welchol Tablets, in the US market.  

The company's abbreviated new drug application (ANDA) for this product was recently approved by the US Food and Drug Administration (US FDA).  

The Welchol brand, which is a registered trademark of Daiichi Sankyo, Inc, and generics had US sales of approximately $471 million for the most recent twelve months ending in August 2018, the company said, while quoting the IMS Health data.

Dr Reddy's Colesevelam Hydrochloride tablets is available in

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in